Geranylgeraniol supplementation leads to an improvement in inflammatory parameters and reversal of the disease specific protein signature in patients with hyper-IgD syndrome
Anna Sediva, Martin Orlicky, Petra Vrabcova, Adam Klocperk, Tomas Kalina, Hideji Fujiwara, Fong-Fu Hsu, View ORCID ProfileMonika Bambouskova
doi: https://doi.org/10.1101/2024.07.17.24309492
Anna Sediva
1Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
Martin Orlicky
1Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
Petra Vrabcova
1Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
Adam Klocperk
1Department of Immunology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
Tomas Kalina
2Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic
Hideji Fujiwara
3Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St. Louis, MO, 63110, USA
Fong-Fu Hsu
3Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St. Louis, MO, 63110, USA
Monika Bambouskova
3Division of Endocrinology, Metabolism & Lipid Research, Washington University School of Medicine, St. Louis, MO, 63110, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted July 18, 2024.
Geranylgeraniol supplementation leads to an improvement in inflammatory parameters and reversal of the disease specific protein signature in patients with hyper-IgD syndrome
Anna Sediva, Martin Orlicky, Petra Vrabcova, Adam Klocperk, Tomas Kalina, Hideji Fujiwara, Fong-Fu Hsu, Monika Bambouskova
medRxiv 2024.07.17.24309492; doi: https://doi.org/10.1101/2024.07.17.24309492
Geranylgeraniol supplementation leads to an improvement in inflammatory parameters and reversal of the disease specific protein signature in patients with hyper-IgD syndrome
Anna Sediva, Martin Orlicky, Petra Vrabcova, Adam Klocperk, Tomas Kalina, Hideji Fujiwara, Fong-Fu Hsu, Monika Bambouskova
medRxiv 2024.07.17.24309492; doi: https://doi.org/10.1101/2024.07.17.24309492
Subject Area
Subject Areas
- Addiction Medicine (341)
- Allergy and Immunology (665)
- Anesthesia (180)
- Cardiovascular Medicine (2624)
- Dermatology (221)
- Emergency Medicine (397)
- Epidemiology (12169)
- Forensic Medicine (10)
- Gastroenterology (755)
- Genetic and Genomic Medicine (4061)
- Geriatric Medicine (384)
- Health Economics (675)
- Health Informatics (2620)
- Health Policy (997)
- Hematology (359)
- HIV/AIDS (843)
- Medical Education (398)
- Medical Ethics (109)
- Nephrology (429)
- Neurology (3829)
- Nursing (209)
- Nutrition (569)
- Oncology (2005)
- Ophthalmology (581)
- Orthopedics (238)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (471)
- Pediatrics (1107)
- Primary Care Research (447)
- Public and Global Health (6496)
- Radiology and Imaging (1388)
- Respiratory Medicine (869)
- Rheumatology (400)
- Sports Medicine (338)
- Surgery (441)
- Toxicology (52)
- Transplantation (185)
- Urology (165)